Symphony's analyst price target has been revised downward from $1,262.25 to $1,181.86. Analysts cite adjustments to key growth and profitability expectations in light of updated financial projections.
What's in the News
- The Board of Directors will meet on November 6, 2025, to review unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2025 (Key Developments).
- The agenda for the Board Meeting will also include consideration and potential declaration of the second interim dividend on equity shares for the financial year 2025-26 (Key Developments).
Valuation Changes
- Fair Value: Decreased from ₹1,262.25 to ₹1,181.86, reflecting a downward revision in analyst expectations.
- Discount Rate: Increased slightly from 14.94% to 15.00%, indicating a modestly higher assumed risk profile.
- Revenue Growth: Projected growth has increased from 4.28% to 4.76%. This suggests slightly improved optimism for future sales.
- Net Profit Margin: Upgraded from 18.95% to 21.12%. This points to anticipated improvements in profitability.
- Future P/E: Lowered notably from 42.31x to 32.27x. This indicates a reduced valuation multiple expectation.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.